IOX 2
98%
- Product Code: 101019
CAS:
931398-72-0
| Molecular Weight: | 352.34 g./mol | Molecular Formula: | C₁₉H₁₆N₂O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
IOX 2 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a selective inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH), making it a valuable tool in research focused on understanding and modulating the hypoxia response pathway. By inhibiting HIF-PH, IOX 2 stabilizes hypoxia-inducible factors (HIFs), which play a critical role in cellular responses to low oxygen levels. This mechanism is particularly relevant in studies related to anemia, as HIF stabilization can stimulate erythropoiesis (red blood cell production). Additionally, IOX 2 is employed in research exploring conditions such as ischemia, cancer, and inflammatory diseases, where hypoxia and HIF signaling pathways are implicated. Its application extends to preclinical studies aimed at developing therapeutic agents targeting oxygen-sensing pathways.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿5,450.00 |
+
-
|
| 0.025 | 10-20 days | ฿19,100.00 |
+
-
|
| 0.100 | 10-20 days | ฿48,200.00 |
+
-
|
IOX 2
IOX 2 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a selective inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH), making it a valuable tool in research focused on understanding and modulating the hypoxia response pathway. By inhibiting HIF-PH, IOX 2 stabilizes hypoxia-inducible factors (HIFs), which play a critical role in cellular responses to low oxygen levels. This mechanism is particularly relevant in studies related to anemia, as HIF stabilization can stimulate erythropoiesis (red blood cell production). Additionally, IOX 2 is employed in research exploring conditions such as ischemia, cancer, and inflammatory diseases, where hypoxia and HIF signaling pathways are implicated. Its application extends to preclinical studies aimed at developing therapeutic agents targeting oxygen-sensing pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :